Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling.

Nelson HH, Marsit CJ, Christensen BC, Houseman EA, Kontic M, Wiemels JL, Karagas MR, Wrensch MR, Zheng S, Wiencke JK, Kelsey KT.

Epigenetics. 2012 Jun 1;7(6):559-66. doi: 10.4161/epi.20219.

2.

Lung cancer: from single-gene methylation to methylome profiling.

Heller G, Zielinski CC, Zöchbauer-Müller S.

Cancer Metastasis Rev. 2010 Mar;29(1):95-107. doi: 10.1007/s10555-010-9203-x. Review.

PMID:
20099008
3.
4.

The role of DNA methylation in the development and progression of lung adenocarcinoma.

Kerr KM, Galler JS, Hagen JA, Laird PW, Laird-Offringa IA.

Dis Markers. 2007;23(1-2):5-30. Review.

5.

The role of DNA methylation as biomarkers in the clinical management of lung cancer.

Fleischhacker M, Dietrich D, Liebenberg V, Field JK, Schmidt B.

Expert Rev Respir Med. 2013 Aug;7(4):363-83. doi: 10.1586/17476348.2013.814397. Review.

PMID:
23964627
6.

[Lung cancer and epigenetic modifications].

Darılmaz Yüce G, Ortaç Ersoy E.

Tuberk Toraks. 2016 Jun;64(2):163-70. Review. Turkish.

7.

Genomics of squamous cell lung cancer.

Rooney M, Devarakonda S, Govindan R.

Oncologist. 2013 Jun;18(6):707-16. doi: 10.1634/theoncologist.2013-0063. Review.

8.

Epigenetics of lung cancer.

Langevin SM, Kratzke RA, Kelsey KT.

Transl Res. 2015 Jan;165(1):74-90. doi: 10.1016/j.trsl.2014.03.001. Review.

9.

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications.

Ocak S, Sos ML, Thomas RK, Massion PP.

Eur Respir J. 2009 Aug;34(2):489-506. doi: 10.1183/09031936.00042409. Review.

10.

DNA methylation biomarkers to assess therapy and chemoprevention for non-small cell lung cancer.

Belinsky SA, Schiller JH, Stidley CA.

Nutr Rev. 2008 Aug;66 Suppl 1:S24-6. doi: 10.1111/j.1753-4887.2008.00061.x. Review. No abstract available.

Supplemental Content

Support Center